ELC Group elects Biffignandi to board
This article was originally published in Scrip
The former president of The Organisation for Professionals in Regulatory Affairs (TOPRA), Dr Paolo Biffignandi, has joined the advisory board at ELC Group. Dr Biffignandi, who has more than 30 years' experience in regulatory affairs and pharmacovigilance, is a renowned physician, a fellow of TOPRA and an overseas fellow of the Royal Society of Medicine. ELC Group is a provider of outsourced development services to the pharma, biotech and medical device industries, as well as REACH services to the chemical industry.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.